Insights

Palla Pharma (ASX:PAL) share price rockets 30% higher. Here’s why

The Palla Pharma Ltd (ASX: PAL) share price is up 30% today after the company announced a change in its manufacturing facility.
The post Palla Pharma (ASX:PAL) share price rockets 30% higher. Here’s why appeared first on The Motley Fool Australia. –

Rocket soaring through sky

The Palla Pharma Ltd (ASX: PAL) share price is among the top performers on the ASX market today. This comes after the company announced that it had received approval to change its manufacturing site to its Norway production facility.

During late afternoon trade, shares in the opiate-based pain relief medicine company are up 30.3% to 73 cents. It’s worth noting that the company’s shares rose to an intraday high of 82 cents in the first hour of market open.

Production facility change

The Palla Pharma share price is on the move after reporting a significant tailwind in its operations.

In today’s release, Palla Pharma advised that United Kingdom’s medicines regulator, MHRA, has given the green light to change the manufacturing site for its Co-Codamol tablet.

Palla Pharma’s Co-Codamol products contain two painkilling ingredients, paracetamol and codeine. The tablet form product relieves short-lasting painful conditions where paracetamol alone is insufficient.

In addition to the approval, the regulator also gave the nod for the company’s required marketing authorisations, as well as patient information leaflets and product packaging.

As a result, Palla Pharma immediately began producing its initial batches of the product in bulk. Once it has completed the packing process, it will move onto its sales process. The company noted that production would ramp up to meet the anticipated demand for the coming months.

The UK is the biggest market in Europe for painkiller relief tablets. Each kilogram of codeine phosphate sold as part of the approved Co-Codamol product has a higher gross margin than in active pharmaceutical ingredient form or tableted form as a contract manufacturer. This in-turn represents an increase in revenue generation for the company.

Palla Pharma revealed that it would release its full-year results on Friday, 26 February.

About the Palla Pharma share price

The Palla Pharma share price has taken investors on a rollercoaster ride in the past 12 months. The company’s shares dipped to an all-time low of 45 cents in March, before storming to a 52-week high of $1.08.

At today’s current share price of 72 cents, Palla Pharma is down around 15% from this time last year.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Palla Pharma (ASX:PAL) share price rockets 30% higher. Here’s why appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!